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Abstract
Polyunsaturated fatty acids (PUFAs) form a class of essential micronutrients that play a vital role in development,
cardiovascular health, and immunity. The influence of lipids on the immune response is both complex and diverse, with
multiple studies pointing to the beneficial effects of long-chain fatty acids in immunity. However, the mechanisms through
which PUFAs modulate innate immunity and the effects of PUFA deficiencies on innate immune functions remain to be
clarified. Using the Caenorhabditis elegans–Pseudomonas aeruginosa host–pathogen system, we present genetic evidence
that a D6-desaturase FAT-3, through its two 18-carbon products—gamma-linolenic acid (GLA, 18:3n6) and stearidonic acid
(SDA, 18:4n3), but not the 20-carbon PUFAs arachidonic acid (AA, 20:4n6) and eicosapentaenoic acid (EPA, 20:5n3)—is
required for basal innate immunity in vivo. Deficiencies in GLA and SDA result in increased susceptibility to bacterial
infection, which is associated with reduced basal expression of a number of immune-specific genes—including spp-1, lys-7,
and lys-2—that encode antimicrobial peptides. GLA and SDA are required to maintain basal activity of the p38 MAP kinase
pathway, which plays important roles in protecting metazoan animals from infections and oxidative stress. Transcriptional
and functional analyses of fat-3–regulated genes revealed that fat-3 is required in the intestine to regulate the expression of
infection- and stress-response genes, and that distinct sets of genes are specifically required for immune function and
oxidative stress response. Our study thus uncovers a mechanism by which these 18-carbon PUFAs affect basal innate
immune function and, consequently, the ability of an organism to defend itself against bacterial infections. The conservation
of p38 MAP kinase signaling in both stress and immune responses further encourages exploring the function of GLA and
SDA in humans.
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Introduction
Polyunsaturated fatty acids (PUFAs) are a class of long chain
fatty acids of 18 carbon atoms or more in length that contain two
or more double bonds. PUFAs are classified into two groups, the
omega-6 (n-6) or the omega-3 (n-3) fatty acids, depending on the
position of the double bond (n) closest to the methyl end of the
fatty acid chain. In mammals, the 18-carbon and longer omega-6
and omega-3 PUFA families cannot be synthesized de novo. They
are produced, instead, from the dietary essential fatty acids linoleic
acid (LA, 18:2n6) and alpha-linolenic acid (ALA, 18:3n3) through
a series of desaturation and elongation reactions catalyzed by
desaturase and elongase enzymes, respectively [1,2]. Omega-6
PUFAs, such as arachidonic acid (AA, 20:4n6) are converted into
eicosanoids, leukotrienes and prostanoids through the actions of
lipoxygenase and cyclooxygenase enzymes [3]. In vertebrates,
these eicosanoids variously exert stimulatory and inhibitory
influences and have profound effects on multiple aspects of
organismal physiology, including immunity [4,5]. For example,
prostaglandins and leukotrienes are pro-inflammatory mediators
that are vital for the initial containment of an infection and for the
recruitment of phagocytes and other immune cells to a site of
infection [6]. Omega-3 fatty acids such as eicosapentaenoic acid
(EPA, 20:5n3) influence the T cell response to infection and
demonstrate strong anti-inflammatory effects [7]. Dietary fatty
acids and eicosanoids have also been shown to bind nuclear
receptors, such as the Peroxisome Proliferator Activated Receptor
c (PPAR-c), which modulates activation of dendritic cells, NK cells
and T cells [8–10]. The influence of PUFAs on immune functions
also extends to other organisms that possess only an innate
immune response. For example, eicosanoids are crucial mediators
and coordinators of insect cellular immune reactions to bacterial,
fungal, and parasitoid invaders, specifically microaggregation,
nodulation, and encapsulation [11]. In the silkworm Bombyx mori,
eicosanoids are involved in the expression of the antibacterial
proteins cecropin and lysozyme in the fat body [12]. In Drosophila,
a functional coupling between eicosanoid biosynthesis and the
IMD pathway for the induction of the antibacterial peptide
diptericin by LPS has been reported [13,14]. An analogous fatty
acid-derived signaling pathway has also been shown to be
important for defense in plant. However, instead of the 20-carbon
AA, which is a minor PUFA in plants, 18-carbon PUFAs serve as
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oxylipins that play important roles in pathogen defense [15].
Jasmonates regulate the expression of defense genes that are
essential for survival against insects and necrotrophic pathogens
[16]. Oxylipins, such as crepenynic and dehydrocrepenynic acids
are biologically active anti-fungal compounds [17].
Innate immunity forms a common first line of defense for most
organisms, providing a highly conserved but generally non-specific
response to pathogens and parasites. The innate immune system
can be distinguished into two separate but overlapping compo-
nents, the constitutive or basal branch of innate immune defense,
and the pathogen-induced responses [18,19]. Constitutive or basal
immunity involves the constant production of effector molecules
such as defensins and other antimicrobial peptides, providing a
preventative barrier and allowing the organism to instantaneously
respond to an immunological insult [20–22]. The inducible
branch of the innate immune system, on the other hand, is only
activated after the host has encountered a pathogen, and typically
includes the induction of additional effector molecules, and where
present, the recruitment and activation of phagocytic cells [23].
Both constitutive and inducible innate immunity has been
described in the soil nematode C. elegans. For example, a number of
antimicrobial peptides are constitutively expressed in healthy
worms, including lysozymes [24], the ABF-2 defensin [25] and the
SPP-1 saposin [24]. A subset of these constitutively-expressed
antimicrobials, and a suite of additional effector molecules,
including members of the C-type lectin family, are up-regulated
at different time points after infection [26–28]. The ability of C.
elegans to defend against infections requires several conserved
signaling pathways [19,29,30]. They include a MAP kinase
cascade, resulting in the activation of the p38 MAP kinase
homologue PMK-1 [29], an insulin-like defense pathway that
activates the FOXO transcription factor homologue DAF-16 [31]
and a TGF-b pathway [26]. These pathways are required for the
elevated production of a number of effector molecules, including
antimicrobial peptides, lysozymes and lectins, to levels above those
seen under basal conditions, in healthy worms [24,28]. The p38
MAP kinase pathway also plays a vital role in maintaining the
basal immune response, and mutants in this pathway, such as the
p38 MAP kinase mutant pmk-1, show defects in the constitutive
expression of lysozymes, lectins and other effector molecules [28].
In addition to the innate immune response, pathways for lipid
synthesis and metabolism are also largely conserved in C. elegans
[32–34], making the worm an ideal model to investigate the effects
of lipids on immune function. Unlike mammals, C. elegans is able to
synthesize all its required long chain fats from its bacterial food
source (Figure 1A), allowing for the manipulation of lipid synthesis
and content in the worm [32,35]. Synthesis of these fatty acids is
catalyzed by elongase and desaturase enzymes, which in C. elegans
are encoded by elo and fat genes, respectively, and the C. elegans
genome contains the full complement of enzymes required for the
synthesis of long chain fatty acids (LCFAs) [32,35]. The absence of
obvious mammalian orthologs of cyclooxygenases and lipoxygen-
ases or of prostanoid and leukotriene receptors in the C. elegans
genome [36] provides the opportunity to investigate the roles for
PUFAs in innate immunity that could otherwise be masked by the
dominant influences of the prostaglandin and leukotriene
eicosanoids.
Here, we use the infection of C. elegans by a human Gram-
negative bacterial pathogen, Pseudomonas aeruginosa as an experi-
mental system to investigate the interplay between PUFAs and
innate immunity, in the context of the whole organism. We
identify two long chain PUFAs, gamma-linolenic acid (GLA,
18:3n6) and stearidonic acid (SDA, 18:4n3), as vital for C. elegans
defense against P. aeruginosa infection. Disrupting the production of
these two fatty acids results in increased mortality following
exposure to the pathogen. We demonstrate, by deficiency and
exogenous supplementation studies, that GLA and SDA are
required for both the basal activity of the p38 MAP kinase
pathway and the basal expression of immunity genes.
Results
P. aeruginosa Infection Alters LCFA Synthesis and
Composition
Although lipids are known to play multiple roles in immunity,
relatively little evidence exists for the specific manipulation of the
lipid metabolism in response to infection. Detailed analysis of a
whole genome microarray study for gene expression in P.
aeruginosa-infected C. elegans [27] revealed an enrichment for genes
required for the synthesis of LCFAs. This modulation of the lipid
metabolism in response to infection hinted at potential roles for
fatty acids in C. elegans immunity. To confirm and extend the
microarray observations, we used quantitative real time PCR
(qRT-PCR) to compare mRNA levels of 16 LCFA synthesis genes
in age-matched adult animals raised on E. coli OP50-1, the
standard laboratory food source, or following infection by P.
aeruginosa strain PA14 (Figure 1B). Since the activity of lipid
metabolism genes could be greatly influenced by available
nutritional sources, and having determined that the fatty acid
contents of E. coli and P. aeruginosa were different (Figure S1A), we
also quantified the mRNAs of elo and fat genes in worms exposed
to PA14DgacA, an isogenic strain of P. aeruginosa PA14 in which the
global virulence gene gacA, has been deleted [37]. PA14DgacA
mutants were highly attenuated in their ability to kill C. elegans
(Figure S1B) [38], but had a fatty acid composition very similar to
the parental PA14 strain (Figure S1A), thus providing a useful
control for changes due to nutritional differences between E. coli
and P. aeruginosa. Of the nine C. elegans genes known to be involved
in the synthesis of the majority of 18- and 20-carbon PUFAs and
monounsaturated fatty acids (MUFAs), fat-6, fat-2, fat-3 and fat-4
were expressed at higher levels in worms exposed to P. aeruginosa
than to E. coli or PA14DgacA (Figure 1B). These represent genes
Author Summary
Polyunsaturated fatty acids are vital for optimal physio-
logical functions, including immunity. Much of these
effects are mediated by eicosanoids, which are metabolites
of arachidonic acid (AA) and eicosapentaenoic acid (EPA).
In mammals, PUFAs cannot be synthesized de novo. They
are produced from essential dietary fatty acids, which are
first converted to gamma-linolenic acid (GLA) and stear-
idonic acid (SDA) by a rate-limiting step catalyzed by a D6-
desaturase, FADS2. Activity of FADS2 is impaired under
numerous conditions—including aging, diabetes, stress,
and smoking—and could lead to reduced production of
GLA and SDA. In this study, we examined the effects of
loss-of-function mutations in PUFA biosynthetic genes on
the ability of C. elegans to survive infection by the Gram-
negative human pathogen P. aeruginosa. We show that
the enhanced pathogen susceptibility of the C. elegans D6-
desaturase mutant fat-3 is associated with decreased basal
expression of immunity genes and disrupted activity of the
p38 MAP kinase. These defects could be fully restored
when both GLA and SDA, but not AA or EPA, were added
into the diets of fat-3 mutants, further supporting the
conclusion that GLA and SDA are required for basal
immunity in C. elegans.
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conditions, indicating a modulation of PUFA synthesis by P.
aeruginosa infection. Of the five elo genes of unknown function, elo-7
and elo-8 were also significantly induced under infection conditions
(Figure 1B). Although expression of fat-5, elo-9 and the branched
chain fatty acid (BCFA) biosynthetic genes (elo-5 and elo-6) were
lower in animals exposed to P. aeruginosa compared to E. coli
(Figure 1B), they were also lower in animals exposed to attenuated
PA14DgacA, suggesting that these changes in expression may be
due to differences in fatty acid content between the bacterial
species. These results confirmed a specific modulation of host
LCFA synthesis in response to P. aeruginosa infection.
We next determined the effect of infection on the abundance of
specific fatty acids in the worm. Gas chromatography followed by
mass spectrometry (GC-MS) [32] was used to identify and
compare the content of individual species of LCFAs in age-
Figure 1. PUFA synthesis and composition are altered with P. aeruginosa infection. A. Schematic of the LCFA synthesis pathway in C.
elegans, adapted from [32]. Diagram depicts all known steps in PUFA synthesis as well as the elongase and desaturase enzymes involved. Shaded
section depicts synthesis of PUFAs from their monounsaturated precursors. B. qRT-PCR analysis of mRNA expression of LCFA synthesis genes in
response to P. aeruginosa (PA14) infection. Data from three independent experiments were normalized as indicated in Materials and Methods and are
depicted as mean6s.e.m., relative to age-matched animals feeding on E. coli OP50-1. *, p#0.05 in the comparison between OP50-1 and PA14;
m,
p#0.05 in the comparison between PA14 and PA14DgacA; Student’s t-test. C. Relative abundance of select LCFA in PA14-infected animals. GC-MS
analysis was used to measure and identify the individual fatty acid species. LCFA levels are expressed as fraction of total long chain fatty acids and are
depicted as mean6s.e.m. from three independent experiments. *, p#0.001 in the comparison between E. coli and PA14;
m,p #0.001 in the
comparison between PA14 and PA14DgacA; Student’s t-test. Abbreviations: AA, arachidonic acid; ALA, alpha-linolenic acid; DGLA, dihomo-c-linolenic
acid; EPA, eicosapentaenoic acid; GLA, gamma-linolenic acid; LA, linoleic acid; O3AA, v-3 arachidonic acid; OA, oleic acid; PA, palmitic acid; PLA,
palmitoleic acid; SA, stearic acid; VA, vaccenic acid.
doi:10.1371/journal.pgen.1000273.g001
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To rule out changes caused by nutritional differences between the
two bacterial species, we also determined LCFA content of worms
exposed to PA14DgacA mutant bacteria. We conclude that the
higher levels of vaccenic acid (VA, 18:1n7) in P. aeruginosa-infected
worms is most likely due to nutritional differences between P.
aeruginosa and E. coli because the same increase was seen in worms
that were exposed to the relatively avirulent PA14DgacA
(Figure 1C). This is consistent with GC-MS results showing that
both the P. aeruginosa and PA14DgacA strains had more than twice
the VA content compared to E. coli (Figure S1A). Worms infected
with P. aeruginosa had significantly lower levels of stearic acid (SA,
18:0), oleic acid (OA, 18:1n9), LA, ALA and GLA compared to
worms exposed to E. coli or the attenuated PA14DgacA strains
(Figure 1C). These changes in PUFA content also corresponded
with the previously observed infection-induced changes in gene
expression. Three of the genes up-regulated in response to
infection, fat-6, fat-2 and fat-3, are involved in the synthesis of
fatty acids listed above, potentially indicating a feedback loop,
where decreases in LCFA levels during infection could induce
increased expression of corresponding biosynthetic genes. The
infection-specific decreases in fatty acid levels led us to hypothesize
that these LCFAs may be involved in immunity against pathogens.
PUFA Composition Affects Immune Function
To determine if specific LCFAs could be important for immune
function in vivo, we analyzed a series of mutants that were unable to
synthesize specific MUFAs and/or PUFAs for their ability to survive
infectionbyP. aeruginosa (Figure 2A).These strong or complete loss-of-
function mutants in the fat and elo genes were also analyzed by GC-
MSto confirm that the genetic lesion or RNAi knockdown resulted in
the expected alterations in the fatty acid profile (Figure 2A). The
ELO-2 elongase is thought to catalyze the elongation of palmitic acid
(PA, 16:0) to SA (Figure 1A). Reducing elo-2 expression by RNAi
resulted in significant changes in LCFA profile that is consistent with
a previous report [39] and a significant increase in susceptibility to
killing by P. aeruginosa (Figure 2A). The next step in PUFA synthesis,
the conversion of SA to OA is catalyzed by two functionally-
redundant desaturases, encoded by fat-6and fat-7 (Figure 1A)[40,41].
We verified previous reports that neither the loss of fat-6 nor fat-7
function resulted in any significant alteration in PUFA composition,
and showed that neither mutant was susceptible to P. aeruginosa
infection (Figure 2A).By contrast, the fat-6(tm331); fat-7(wa36) double
mutant, which lacked OA and the 18- and 20-carbon PUFAs derived
from OA [41], was highly susceptible to killing by P. aeruginosa. fat-
2(wa17) animals that lacked all 18- and most 20-carbon PUFAs were
also significantly more susceptible to P. aeruginosa (Figure 2A). Loss of
fat-3(wa22) function resulted in animals that lacked two specific 18-
carbon PUFAs, GLA and SDA, as well as all the 20-carbon PUFAs.
fat-3(wa22) animals were also significantly more susceptible to
infection, suggesting that GLA, SDA and/or 20-carbon PUFAs that
were missing in these animals could be vital for infection response in
C. elegans (Figure 2A). Interestingly, two different elo-1 mutants, elo-
1(gk48) and elo-1(wa7), that had decreased levels of all the 20-carbon
PUFAs but accumulated the upstream 18-carbon precursors GLA
and SDA [32], were significantly more resistant to killing by P.
aeruginosa (Figure 2A). These results suggest that a lack of 20-carbon
PUFAs does not compromise immune function. Consistent with this
interpretation, neither the fat-1(wa9) mutant lacking two 20-carbon
PUFAs, dihomo-c-linolenic acid (DGLA, 20:3n6) and EPA, nor two
fat-4 mutants, fat-4(wa14) and fat-4(ok958), that lacked AA and EPA,
were significantlydifferent from wild-type animalsfor susceptibility to
P. aeruginosa (Figure 2A). Collectively, resistance of the elo-1 mutants
and increased susceptibility of the fat-3(wa22) mutants to P. aeruginosa,
suggest that GLA and SDA that accumulated in the elo-1 mutants but
were absent in the fat-3(wa22) mutant may be required for immune
function.
Dietary Supplementation with GLA and SDA Rescues
Immune Defects
PUFA levels in fat and elo mutants could be restored through
dietary supplementation of the missing fatty acids [42]. To confirm
the requirement of GLA and SDA for C. elegans to survive a
pathogen challenge, fat-2(wa17), fat-3(wa22) and elo-1(gk48)
mutants were raised from embryos to 1-day-old adults in the
presence of exogenously supplied PUFAs. A sub-population of
these PUFA-supplemented adults was subjected to GC-MS to
confirm that the procedure effectively restored the levels of the
missing PUFAs (Figure S2) while the remaining population was
subjected to survival assays. In parallel, wild-type worms were also
supplemented with the respective PUFAs and the PUFA levels
following supplementation were determined by GC-MS (Figure
S2A). PUFA-supplemented wild-type animals were not signifi-
cantly different from untreated wild-type for pathogen survival
(Table 1, Figures S3A and S3B). Supplementation with ALA
completely restored PUFA levels (data not shown) and survival of
fat-2(wa17) animals on P. aeruginosa to that of wild-type (Figure 2B).
ALA supplementation, however, failed to rescue fat-3(wa22)
susceptibility to P. aeruginosa (Figure 2D, Table 1). These results
were expected because the fat-3 gene remained functional in the
fat-2(wa17) mutant and could convert the exogenously added ALA
into the required downstream fatty acids, thus rescuing the
immune defects of fat-2(wa17) animals. The fat-3(wa22) mutant, on
the other hand, was unable to process the supplied ALA, and
consequently remained susceptible to P. aeruginosa. We, therefore,
conclude that ALA is not directly required for immune function.
Instead, ALA is likely to be modified by the FAT-3 D6-desaturase
enzyme into functional molecules that affect immune function.
Supplementation with either GLA or SDA that were absent in
both the fat-2(wa17) and fat-3(wa22) mutants, resulted in a partial
rescue of pathogen susceptibility (Figure 2B, C). GLA supplemen-
tation increased the mean survival period of both the fat-2(wa17)
and fat-3(wa22) mutants to approximately 90% of wild-type. GLA
supplementation limited to only the adult stage was also sufficient to
partially rescue the susceptibility of the fat-3(wa22) mutant (Figure
S3C), suggesting that the presence of GLA during growth and
development is not necessary for its effect on the survival against P.
aeruginosa infection. Addition of SDA alone increased the mean
survival period of both fat-2(wa17) and fat-3(wa22) mutants on P.
aeruginosa to approximately 85% of wild-type (Figure 2B, C).
Supplementation with both GLA and SDA, however, completely
rescuedfat-3(wa22)survivalagainstP.aeruginosainfection(Figure2C,
Table 1), indicating that GLA and SDA together are required for
optimal infection response. We also note that, similar to the
association between pathogen resistance and accumulation of GLA
and SDA seen with elo-1 mutants (Figure 2A), wild-type and fat-
3(wa22) animals supplemented with both GLA and SDA were
marginally more resistant to P. aeruginosa, although these increases
were not statistically significant (Table 1).
The P. aeruginosa-resistant elo-1(gk48) animals were also supple-
mented with ALA, GLA and SDA. The elo-1(gk48) mutant already
accumulated these same fatty acids (Figure 2A), and additional
supplementation did not enhance pathogen resistance (Figure S3D).
Pathogen resistance of elo-1(gk48), coupled with wild-type pheno-
types of the fat-1(wa9), fat-4(wa14) and fat-4(ok958) mutants on P.
aeruginosa (Figure 2A), indicate that 20-carbon PUFAs are not
necessary for C. elegans immunity. To further support these
conclusions, we analyzed the effect of supplementation with AA
PUFAs Modulate C. elegans Immunity
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either AA or EPA to fat-3(wa22) animals effectively restored the
respective PUFAs in these animals (Figure S2C, S2D), but could not
rescue pathogen sensitivity of the fat-3(wa22) mutant (Figure 2D),
confirming that the 20-carbon PUFAs do not have any detectable
roles in immune function. These results further implicate the
requirement for both GLA and SDA in C. elegans immunity.
Intestinal PUFA Synthesis Mediated by FAT-3 Is Important
for Immune Function
The fat-3 gene is expressed in multiple tissues, including the
intestine, pharynx and body wall muscles, as well as some head
and tail neurons [42]. To determine the tissue in which the fat-3
gene is required for immune function, we obtained transgenic
strains that express a functional fat-3 gene only in the neurons, the
muscles or the intestine of a fat-3 mutant using well-established
tissue-specific promoters [36] and assayed the ability of these
animals to survive P. aeruginosa infection. We first confirmed that
the two deletion alleles of fat-3 used to generate the tissue-specific
rescue strains, fat-3(lg8101) and fat-3(lg8101/qa1811) [36], dem-
onstrated equivalent susceptibilities as fat-3(wa22) [32] to P.
aeruginosa (Figure 3A). The fat-3; [Pfat-3::fat-3] strain, carrying a
transgene consisting of the endogenous fat-3 promoter and the fat-
3 coding region in the fat-3(lg8101) mutant [36], showed wild-type
survival on P. aeruginosa, confirming that pathogen sensitivity is a
direct consequence of loss of fat-3 function (Figure 3A, Table 2).
fat-3; [Punc-119::fat-3] transgenic animals expressing the fat-3
Figure 2. GLA and SDA are required for survival against P. aeruginosa. A. Fatty acid composition of PUFA synthesis mutants and their survival
on P. aeruginosa. Mean time to death relative to wild-type (mutant TDmean / wild-type TDmean)o nP. aeruginosa (PA14) is shown: Values greater than 1
indicate extended survival on PA14, while values less than one indicate decreased survival relative to wild-type. Fatty acid composition as determined
by GC-MS and depicted as percent of total fatty acids measured. Size of each circle represents relative amount of individual fatty acid species in the
mutant. # SDA levels for elo-1(wa7) are as reported in [32] and for elo-1(gk48) are as indicated in [39], as this fatty acid was not resolvable in the GC
column used in this study. D Fatty acid composition shown for the fat-6(tm331); fat-7(wa36) double mutant is based on a published report [41]. B–D.
Rescue of fat-2(wa17) and fat-3(wa22) survival defects by exogenous fatty acid supplementation. Age-matched adults were monitored for survival
against PA14 infection. Graphs depict fraction of worms alive plotted as a function of time. Wild-type, fat-2(wa17) and fat-3(wa22) animals were
supplemented with ethanol, the fatty acid solvent used in these experiments. B. Survival analysis of the fat-2(wa17) mutant supplemented with three
different 18-carbon PUFAs. C. Survival analysis of the fat-3(wa22) mutant supplemented with GLA or SDA, or simultaneous supplementation with
both fatty acids. D. Survival analysis of the fat-3(wa22) mutant supplemented with ALA, AA or EPA. *, p#0.001 relative to wild-type within the same
set of experiments; Kaplan Meier non-parametric comparison and a Logrank test. Abbreviations: AA, arachidonic acid; ALA, alpha-linolenic acid; EPA,
eicosapentaenoic acid; GLA, gamma-linolenic acid; LA, linoleic acid; SDA, stearidonic acid.
doi:10.1371/journal.pgen.1000273.g002
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promoter, however, remained significantly more susceptible to P.
aeruginosa (Figure 3B, Table 2). Expression of fat-3 under the
control of the muscle-specific myo-3 promoter also failed to rescue
the fat-3 mutant sensitivity to P. aeruginosa (Figure 3B, Table 2).
Together, these results indicate that fat-3 gene expression and fat-
3-dependent PUFA synthesis in the muscles or neurons does not
significantly affect immune function. By contrast, fat-3; [Pelt-2::fat-
3] transgenic animals expressing the fat-3 gene under the control of
the intestine-specific elt-2 promoter showed survival kinetics on P.
aeruginosa that were indistinguishable from wild-type (Figure 3B,
Table 2). Intestine-specific rescue of fat-3 pathogen sensitivity
indicates that fat-3-dependent synthesis of PUFAs in the intestine is
sufficient for normal immune function in response to bacterial
infection.
The fat-3 Mutant Neuromuscular Defects and Stress
Sensitivities Can Be Dissociated from Immune Defects
Animals that have lost fat-3 gene function display pleiotropic
abnormalities, including impaired motility, a weakened cuticle,
decreased defecation rate and irregular expulsion [36,42]. Many of
these defects are associated with impaired neurotransmission due
the loss of fat-3 function in the neurons [36,42]. We also found that
fat-3(wa22) animals had a marginal but significant decrease in
adult lifespan (Table 1), contrary to a previous report [42].
Together, these defects may indicate a general poor health of fat-3
mutants that could indirectly impact their ability to survive P.
aeruginosa infection. To determine if these pleiotropies could be
dissociated from immune defects, we first analyzed the effects of
PUFA supplementation in fat-3(wa22) animals on these defects, in
addition to survival on P. aeruginosa. We note that, with the possible
exception of AA on adult life span, PUFA supplementations did
not have any significant effects on wild-type animals (Table 1).
Consistent with a previous report, supplementation with GLA [42]
or GLA and SDA combined rescued the defecation and
locomotion defects, and lifespan of fat-3(wa22) animals (Table 1).
GLA and SDA, however, failed to rescue aldicarb resistance
indicating that these PUFAs were not sufficient to restore synaptic
transmission, as measured by acetylcholine release [43] (Table 1).
By contrast, supplementation with either of the 20-carbon PUFAs,
AA or EPA rescued fat-3(wa22) for all the phenotypes tested: adult
lifespan, aldicarb resistance, defecation and locomotion defects
(Table 1). Yet, fat-3(wa22) animals supplemented with either EPA
or AA remained sensitive to P. aeruginosa (Figure 2D, Table 1).
Failure to rescue the fat-3(wa22) immune defect was not due to
insufficient incorporation of EPA or AA because the levels of these
20-carbon PUFAs in the fat-3(wa22) mutants following supple-
mentation was equivalent to, or higher than, in wild-type (Figure
S2C and S2D). Since AA or EPA could rescue fat-3(wa22)
neuronal and muscular defects and adult lifespan but not pathogen
sensitivity, while GLA and SDA rescued pathogen sensitivity, but
not neurotransmission (Figure 2C and 2D, Table 1), we can
conclude that pathogen susceptibility of the fat-3(wa22) mutant
was not due to neuromuscular defects or a shortened adult
lifespan. Instead, pathogen sensitivity of fat-3 mutants is likely to be
caused by factors dependent on levels of GLA and SDA.
This conclusion is further supported by tissue-specific rescue
experiments using transgenic animals. Intestinal expression of the
fat-3 gene only partially rescued the locomotion defects (Table 2)
despite completely rescuing the pathogen sensitivity of the fat-
3(lg8101) mutant (Figure 3B, Table 2). Full rescue of the
defecation defect and the partial rescue of locomotion by intestinal
expression of fat-3 are not surprising because most FAT-3 protein
is in the intestine [42] and it is therefore likely that PUFAs
synthesized in the intestine could be transported to other parts of
the body. As with pathogen sensitivity, muscle-specific expression
of fat-3 was not sufficient to rescue defecation and movement
defects (Table 2). By contrast, neuronal expression of the fat-3 gene
that also failed to rescue pathogen susceptibility (Figure 3B), could
Table 1. PUFA supplementation rescues multiple fat-3(wa22) pleiotropic defects.
Strain
Supplemented
PUFA
PA14 Survival
(TDmean relative to
WT)
Lifespan
(TDmean (days))
Aldicarb (Mean
time to
paralysis (h))
Defecation pBoc
intervals (s)6SD
Locomotion (body
bends/min)6SD
Wild-type none 1.00 12.860.3 16.961.7 48.863.7 206.3612.7
GLA+SDA 1.12 12.760.3 15.961.4 47.265.4 212.0613.9
AA 0.99 13.960.3* 14.861.3 43.663.5 203.0612.5
EPA 0.95 13.160.4 14.761.2 41.167.0 218.0615.2
fat-3(wa22) none 0.63* 11.560.3* 38.463.4* 63.868.6* 66.3612.6*
ALA 0.64* 11.860.4* n.d. 65.267.3* 70.4614.7*
GLA 0.92 13.360.3 33.862.0* 39.365.8 161.3627.7
SDA 0.87* 13.060.4 37.564.3* 58.665.4* 82.269.3*
GLA+SDA 1.04 12.460.3 30.263.1* 42.669.2 201.0610.4
AA 0.65* 13.360.3 18.361.9 48.764.9 185.3617.8
EPA 0.66* 13.460.3 16.561.8 42.167.2 172.5621.3
Survival on P. aeruginosa PA14, adult lifespan, resistance to aldicarb exposure (a measure of neurotransmission), as well as defecation and locomotion of fat-3(wa22) and
wild-type animals supplemented with dietary PUFAs compared to unsupplemented wild-type animals. PA14 survival is reported as mean time to death for each
treatment relative to unsupplemented wild-type (mutant TDmean / wild-type TDmean). Lifespan analysis is reported as mean time to death. Data from aldicarb analyses
are reported as mean time to paralysis within the population tested. Statistical analyses for these three assays were performed using a Kaplan Meier non-parametric
comparison and a Logrank test. For each analysis, a minimum of three independent experiments were performed, each consisting of approximately 120 worms. Analysis
of defecation frequency is depicted as the average interval between successive posterior body contractions (pBoc) and data is shown as mean6SD. of the interval.
Locomotion was assayed as number of body bends in liquid media over a period of two minutes [42], and depicted as average number of body bends per minute. Data
for defecation and locomotion were analyzed by Student’s t-test. In all cases, *, p#0.001 compared to untreated wild-type worms. Abbreviations: AA, arachidonic acid;
ALA, alpha-linolenic acid; EPA, eicosapentaenoic acid; GLA, gamma-linolenic acid; SDA, stearidonic acid.
doi:10.1371/journal.pgen.1000273.t001
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3(lg8101) mutant (Table 2), indicating neuromuscular and
immune functions may be independently regulated by fat-3.
Together, the PUFA supplementation and tissue-specific rescue
experiments indicate that the susceptibility of fat-3 mutants to P.
aeruginosa infection is not associated with neuromuscular and
lifespan defects.
To further rule out the possibility that the increased pathogen
sensitivity of fat-3(wa22) mutants was a consequence of a general
increased sensitivity to any insults, we determined the ability of fat-
3(wa22) animals to survive or develop under a number of
additional stress conditions. We assayed the sensitivity of fat-3
animals to heavy metal stresses by determining the proportion of
embryos that could develop into adults in the presence of toxic
concentrations of cadmium or copper metals [44]. Exposure to
toxic levels of cadmium results in cell damage and is thought to
induce the transcription of a number of defense and repair genes
[45–47]. Following exposure to 30 mM cadmium chloride, less
than 65% of fat-3(wa22) embryos successfully developed into
adults. By contrast, approximately 75% of wild-type embryos grew
to adults, indicating that fat-3(wa22) animals were more sensitive
to cadmium (Table 3). fat-3(wa22) animals were also more sensitive
to copper, with significantly fewer fat-3(wa22) adults than wild-
type developed from embryos following exposure to 250 mM
copper sulfate (Table 3). The fat-3(wa22) mutant was also more
susceptible to a 1% solution of the detergent Triton X-100.
Approximately 26% of fat-3(wa22) animals survived a 1-hour
incubation with the detergent, compared to almost 83% for wild-
type (Table 3). This susceptibility may be associated with the
compromised cuticle of the fat-3 mutant [42], but may also
indicate defects in membrane structure and permeability in fat-
3(wa22) animals due to the absence of long chain unsaturated fatty
acids. Supplementation with GLA and SDA, as well as AA or EPA
fully rescued fat-3(wa22) susceptibility to both heavy metals and to
detergent (Table 3). This may indicate that susceptibility to these
stresses is not specific to a particular PUFA species but dependent,
instead, on the total level of unsaturated fatty acids in the animal.
Importantly, that AA or EPA rescued fat-3(wa22) susceptibility to
these abiotic stresses but not susceptibility to pathogens further
dissociated immune function from general stress resistance in the
fat-3(wa22) mutant.
The physiological temperature that supports C. elegans develop-
ment ranges from 15–25uC [48]. To determine the ability of fat-
3(wa22) animals to tolerate extreme temperatures, we assayed for
the number of one-day old adults that remained alive following
exposure to 36uC and 0uC for a defined period. In contrast to
Figure 3. Intestinal fat-3 expression is required for the infection
response. A. fat-3 is required for immune function. Fraction of worms
alive following exposure to P. aeruginosa, as a function of time, for three
fat-3 alleles and a fat-3(lg1801) strain expressing the fat-3 gene under its
endogenous promoter (Pfat-3::fat-3). B. Intestinal fat-3 expression is
sufficient to rescue survival on P. aeruginosa. Survival analysis of fat-3
transgenic strains expressing the fat-3 gene under the control of tissue
specific promoters. Neuronal- (Punc-119::fat-3) and muscle- (Pmyo-3::fat-
3) specific transgenic rescues were in the fat-3(lg8101) background,
while the intestine specific (Pelt-2::fat-3) rescue was generated in the
fat-3(lg8101/qa1811) mutant [36]. *, p#0.001 relative to wild-type;
Kaplan Meier non-parametric analysis and a Logrank test.
doi:10.1371/journal.pgen.1000273.g003
Table 2. Analysis of tissue-specific fat-3 gene expression on infection survival, defecation and locomotion.
Strain
Transgene
expression
Survival on PA14
(TDmean relative to WT)
Defecation (pBoc
intervals (s))6SD
Locomotion (body
bends/min)6SD
Wild-type - 1.00 48.463.6 231.4618.2
fat-3 (lg8101) - 0.74* 69.864.4* 62.8613.9*
fat-3; [Pelt-2::fat-3] Intestine 0.97 51.766.9 122.4615.2*
fat-3; [Pmyo-3::fat-3] Muscles 0.76* 65.4611.8* 71.9610.4*
fat-3; [Punc-119::fat-3] Neurons 0.81* 49.863.4 174.1633.8
fat-3; [Pfat-3::fat-3] All
# 1.09 45.766.0 193.9621.0
Effects of tissue-specific fat-3 gene expression in the fat-3(lg8101) mutant on infection survival, defecation rate and locomotion compared to wild-type. Assays and
statistical analyses were performed as described in Table 1. In all cases, *, p#0.001 compared to wild-type. # refers to all the tissues in which fat-3 is normally expressed
because the fat-3; [Pfat-3::fat-3] strain expresses fat-3 under the control of its endogenous promoter.
doi:10.1371/journal.pgen.1000273.t002
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resistant than wild-type to extreme temperatures. A significantly
higher proportion of fat-3(wa22 ) than wild-type animals survived
the 36uC heat stress for 10 hours (Table 3) and 12 hours (data not
shown). Similarly, following a 24-hour exposure to 0uC cold stress,
significantly more fat-3(wa22) than wild-type adults remained alive
(Table 3). The findings that supplementation with GLA and SDA
did not restore cold and heat resistance (Table 3), but effectively
restored pathogen sensitivity of the fat-3(wa22) mutant to wild-type
(Table 1) further disassociates resistance to extreme temperatures
from pathogen susceptibility. The observations that fat-3(wa22)
animals were not always more sensitive than wild-type to all the
abiotic insults tested, and that heavy metal and detergent
sensitivity but not immune functions could be rescued by AA or
EPA, further support the hypothesis that susceptibility of the fat-
3(wa22) animals to P. aeruginosa is likely to be due to specific
immune defects.
Immune Gene Expression Is Misregulated in the fat-3
Mutant
The requirement for fat-3 in the intestine, the primary site of P.
aeruginosa infection in C. elegans, raised the possibility that GLA and
SDA could influence immune gene expression. To provide a
further link between fat-3 gene function and innate immunity, we
compared the expression of 50 infection-response genes [49] by
qRT-PCR, in 1-day-old adult wild-type and fat-3(wa22) animals
(Table S1). These 50 genes were selected based on one or more of
the following criteria: a) genes with known or predicted
antimicrobial activity, including spp-1 [50] and abf-2 [25], b)
genes required for survival against P. aeruginosa infection [27,28],
and c) genes known to be differentially regulated in response to P.
aeruginosa infection [27,28]. We quantified the expression of these
genes under normal growth conditions on E. coli to determine
basal or constitutive mRNA levels, and following a 12-hour
exposure to P. aeruginosa to compare mRNA levels in infected
animals (Table S1). The constitutive expression of 22 genes (44%)
was significantly different between age-matched fat-3(wa22) and
wild-type animals raised on E. coli. Of these, 12 genes were
expressed at significantly lower levels (Figure 4A) and 10 were
expressed at significantly higher levels (Table S1) in the fat-3(wa22)
mutant compared to wild-type. These results indicated that the
missing PUFAs in the fat-3(wa22) mutant are required for proper
basal or constitutive expression of a significant subset of infection-
response genes tested. Genes expressed at lower levels in fat-
3(wa22) included three antimicrobial peptide homologs, spp-1,
encoding a saposin-like protein, and two lysozymes, encoded by
lys-2 and lys-7 (Figure 4A). The reduced expression of these
putative antimicrobial genes in uninfected animals raised the
possibility that basal immune function of the fat-3(wa22) mutant
may be compromised. To address this hypothesis, we first
determined if the 12 constitutively down-regulated genes were
required for immunity in wild-type animals. We found that RNAi-
mediated knockdown of spp-1, lys-2, lys-7, dct-17 and F08G5.6
resulted in significantly increased sensitivity to P. aeruginosa-
mediated killing (Table 4). The remaining genes that did not
induce any survival defects on P. aeruginosa following RNAi
knockdown were further tested using a colonization assay.
Comparing the degree of intestinal colonization by PA14-GFP, a
derivative of P. aeruginosa PA14 that expresses the GFP protein
[38], provides a more sensitive measure of the infection process,
allowing us to detect smaller defects in worm immunity. RNAi-
mediated knockdown of lec-11 and F49F1.1 resulted in a
significant increase in the rate of colonization by PA14-GFP
(Figure S4A), despite a wild-type survival phenotype on the
pathogen (Table 4). We henceforth refer to these seven infection-
response genes as immunity genes, due to their role in protecting
C. elegans from infection. The demonstration that a majority of the
genes that were expressed at reduced levels in fat-3(wa22) animals
were functionally important for immunity against P. aeruginosa
provides a potential molecular basis for the sensitivity of the fat-
3(wa22) mutant to infection and suggests that the absence of GLA
and SDA can compromise basal immunity.
We next compared expression levels of the 50 infection-response
genes following a 12-hour infection with P. aeruginosa. The mRNA
levels of only seven genes (14%) were significantly different
between P. aeruginosa-infected fat-3(wa22) and wild-type animals
(Figure S4B, Table S1), indicating that majority of the genes in the
fat-3(wa22) mutant, including a number of genes misregulated
under basal conditions, responded to P. aeruginosa infection to
reach levels similar to the wild-type worm. With the exception of
lys-7, the mRNA levels of all the genes that were constitutively
expressed at lower levels in uninfected fat-3(wa22) animals were
indistinguishable from wild-type following P. aeruginosa infection
(Figure 4B, Table S1), indicating that, at the level of gene
expression, the ability of fat-3(wa22) mutants to respond to
infection remained largely intact. Taken together, these results
Table 3. fat-3(wa22) mutants are sensitive to heavy metal and detergent but not to extreme temperatures.
Strain
Supplemented
PUFA Thermal stress (% alive6s.e.m.) Heavy metals (% adults6s.e.m)
Detergent (%
alive6s.e.m)
36uC (10 h) 0uC (24 h) CuSO4 (250 mM) CdCl2 (30 mM) Triton X-100 (1%)
Wild-type none 60.463.4 67.061.6 79.161.5 74.862.1 82.860.5
fat-3(wa22) none 96.161.7* 87.861.0* 67.760.9* 63.660.7* 26.562.3*
GLA+SDA 90.862.0* 80.260.4* 84.861.4 79.762.0 74.863.6
AA 72.461.4 86.061.1* 75.762.2 73.361.5 85.663.9
EPA 61.961.2 83.261.1* 77.762.0 73.361.5 75.664.4
sek-1(km4) none 63.960.5 65.061.7 55.061.4* 66.460.2* 83.063.0
The effects of mutations and PUFA supplementations on C. elegans sensitivity to abiotic stresses are shown. Sensitivities to extreme temperatures are depicted as
percent of animals alive after the indicated time of exposure to 36uCo r0 uC. Metal toxicity results are depicted as the percent of embryos that successfully developed
into adults in the presence of the indicated concentrations of copper and cadmium metals. Sensitivity to detergent is shown as percent of worms alive after a 1-h
exposure to 1% Triton X-100 solution. *, p#0.001 compared to wild-type animals; Student’s t-test. Abbreviations: AA, arachidonic acid; EPA, eicosapentaenoic acid; GLA,
gamma-linolenic acid; SDA, stearidonic acid.
doi:10.1371/journal.pgen.1000273.t003
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to infection, the significant reduction in constitutive expression of
immunity genes was sufficient to render fat-3(wa22) animals more
susceptible to P. aeruginosa-mediated death. These results under-
score the importance of basal or constitutive immunity for
protection from pathogens.
Given that fat-3 expression in the intestine is required to protect
C. elegans from P. aeruginosa-mediated killing (Figure 3B), we
wondered if expressing fat-3 in the intestine would be sufficient to
restore the expression of infection-response genes in the fat-3
mutants. Infection-response gene expression was quantified by
qRT-PCR in transgenic fat-3 strains that specifically express the
fat-3 transgene in the intestine, muscles or neurons. As these
transgenic strains were constructed in the fat-3(lg8101) back-
ground, we first confirmed that, with the exception of lec-11, the
basal gene expression of the 12 genes assayed were similarly
misregulated in fat-3(lg8101) and fat-3(wa22) relative to wild-type
(Table S2). The reason for this allele-specific effect on lec-11
expression is currently unclear. Excluding lec-11 from the
remaining analysis with transgenic animals, we note that the
Figure 4. Defective basal immune gene expression and p38 MAP kinase activation in the fat-3(wa22) mutant. Expression of 12 infection-
and stress-response genes under normal growth (A) and infection (B) conditions. mRNA expression was quantified by qRT-PCR in wild-type, fat-
3(wa22) and sek-1(km4) 1-day-old adults exposed to OP50-1 (A) or PA14 (B) for 12 h. Data are depicted as mean6s.e.m and represent fold expression
in mutant animals relative to wild-type under the same conditions, with wild-type set to one. A. D,p .0.05 between the fat-3(wa22) and sek-1(km4)
mutants; Student’s t-test. B. *, p,0.05 between fat-3(wa22) and wild-type; Student’s t-test. C–E. Regression analyses of gene expression in uninfected
fat-3(wa22) animals compared to null alleles of sek-1(km4) (C), daf-16(mu86) (D) and sma-6(wk7) (E). Analysis included 22 genes with significantly
altered basal expression in the fat-3(wa22) mutant relative to wild-type (p#0.05). Data were compared using Pearson linear regression analysis with
best fit and t-tests for statistical analyses. Points represent fold difference in gene expression relative to wild-type animals. F. fat-3(wa22) animals
show decreased basal PMK-1 phosphorylation. Immunoblot analysis of PMK-1 activation in uninfected (OP50-1) and infected (PA14) fat-3(wa22)
worms compared to wild-type and sek-1(km4) animals. Lysates from age-matched young adult animals exposed to OP50-1 or PA14 for a period of
12 h were analyzed using a monoclonal antibody specific to the doubly phosphorylated activated form of the p38 protein. Arrow on right indicates
an additional non-specific band seen with the phospho-p38 specific antibody. Anti-actin antibody was used as loading control. G. Survival analysis of
animals exposed to arsenic-induced oxidative stress. One-day-old adult wild-type, sek-1(km4) and fat-3(wa22) animals were placed on plates coated
with a final concentration of 3 mM arsenic and survival was monitored every 12 h. Graph depicts fraction of worms alive plotted as a function of time.
*, p#0.001 relative to wild-type; Kaplan Meier non-parametric comparison and a Logrank test.
doi:10.1371/journal.pgen.1000273.g004
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was sufficient to rescue the expression of all but one of the 11
infection-response genes tested (Figure S5A), indicating that the
requirement for fat-3 in immune function is strongly correlated
with the expression of infection-response genes. Intestine-specific
expression of fat-3 restored the expression of seven of the eight the
down-regulated infection-response genes, including the immune-
specific genes spp-1, lys-7 and F08G5.6 (Figure S5B), indicating
that fat-3 is required in the intestine to regulate basal gene
expression. By contrast, and consistent with the pathogen survival
assay (Figure 3B), expression of fat-3 specifically in the muscles
failed to restore the expression of any of the genes tested, with the
exception of F35E12.8 (Figure S5C). Expression of fat-3 in
neuronal tissues was similarly ineffective at restoring infection-
response gene expression; expression of only two genes, F35E12.8,
and F08G5.6 were restored to wild-type (Figure S5D). Analysis of
spp-1 expression in these transgenic animals is revealing, as spp-1 is
expressed only in the intestine [24]. Expression of spp-1 was
restored to wild-type levels when fat-3 was expressed specifically in
the intestine (Figure S5B) but not in the muscles (Figure S5C) or
neurons (Figure S5D). Together, these data confirm our
hypothesis that fat-3 functions in the intestine to influence the
expression of a number of infection-response genes that contribute
to the protecting C. elegans from P. aeruginosa infection.
Basal p38 MAP Kinase Pathway Activity Is Compromised
in fat-3 Mutants
Of the 12 genes that are positively regulated by fat-3 (Figure 4A),
the expression of lys-2, dod-19, ZK6.11 and F08G5.6 has been
reported to be dependent on the p38 MAP kinase pathway [28]. To
determine if altered constitutive gene expression in the fat-3(wa22)
mutant correlated with defects in p38 MAP kinase signaling, we
compared mRNA levels between fat-3(wa22) and sek-1(km4), a p38
MAP kinase kinase mutant [29], adults raised on E. coli. Using the
set of 22 genes that were significantly altered in fat-3(wa22) animals,
we found that basal gene expression between fat-3(wa22) and sek-
1(km4) animals was highly correlated (Figure 4C), with the
expression of 18 out of 22 genes being similarly altered in both
strains. A majority of these genes, however, were expressed at lower
levels in sek-1(km4) compared to fat-3(wa22) animals (Figure 4A and
C). A similarly significant correlation was seen between fat-3(wa22)
animals and another MAP kinase pathway mutant, the p38 MAP
kinase homolog, pmk-1(km25) (R
2=0.4409, p=0.0008). Significant
correlations in basal gene expression were also seen between fat-
3(wa22) and sek-1(km4) (R
2=0.332, p=0.0001), and between fat-
3(wa22) and pmk-1(km25) (R
2=0.259,p=0.0003) animalswhen the
analysis was extended to the entire 50 gene-set.
In addition to the p38 MAP kinase pathway, the Sma/TGF-
beta and Insulin/Insulin growth factor signal transduction
pathways also play important roles in C. elegans immunity
[19,51,52]. However, basal gene expression in fat-3(wa22) animals
was not significantly correlated with the null allele of the FOXO
transcription factor of the insulin pathway, daf-16(mu86)
(Figure 4D), or the null allele of the Sma/TGF-beta receptor,
sma-6(wk7) (Figure 4E). This high concordance in altered basal
gene expression between fat-3(wa22) and the sek-1(km4) or pmk-
1(km25) mutants led us to hypothesize that the basal activity of the
p38 MAP kinase pathway may be compromised in fat-3(wa22)
animals.
As a direct measure of the effect of the fat-3 mutation on p38
MAP kinase pathway activity, we used immunoblot analyses to
determine the levels of activated PMK-1 protein in fat-3(wa22) and
wild-type age-matched adults raised on E. coli. The sek-1(km4)
mutant, previously shown to have a complete loss of PMK-1
phosphorylation and increased susceptibility to infection [29], was
used as a control. Wild-type worms had detectable levels of
phosphorylated PMK-1 indicating some basal p38 MAP kinase
Table 4. Effect of gene inactivation by RNAi on sensitivity to pathogen infection and arsenic stress.
Group
Gene inactivated by
RNAi Sequence ID Description
Mean time to death relative to
control
Survival on P.
aeruginosa
Survival on
arsenic
Control Empty vector control 1.00 1.00
sek-1 R03G5.2 Mitogen-activated protein kinase 0.80* 0.76*
1 dct-17 F35E12.7 CUB-like domain protein 0.80* 0.81*
F49F1.1 F49F1.1 Metridin-like ShK toxin 0.89
# 0.79*
2 ZK6.11 ZK6.11 DUF-274 domain protein 1.00 0.93
dod-19 ZK6.10 DUF-274 domain protein 0.91 0.90
T01D3.6 T01D3.6 von Willebrand factor and related coagulation proteins 1.01 0.98
3 spp-1 T07C4.4 saposin 0.85* 0.87
lys-2 Y22F5A.5 N-acetylmuraminidase/ lysozyme 0.86* 1.02
lys-7 C02A12.4 N-acetyluuraminidase/ lysozyme 0.85* 0.97
F08G5.6 F08G5.6 CUB-like domain protein 0.82* 0.99
lec-11 F38A5.3 Galactin, Galactose-binding lectin 0.99
# 0.91
4 F35E12.8 F35E12.8 CUB-like domain protein 0.89 0.82*
gst-38 F35E8.8 Glutathione S-transferase 0.97 0.76*
Values represent survival of RNAi-treated animals challenged with P. aeruginosa infection or arsenic-mediated oxidative stress. Survival analysis is depicted as mean time
to death relative to control animals treated with a vector construct with no RNAi target (mutant TDmean / control TDmean). *, p#0.001 compared to control; Kaplan Meier
non-parametric comparisons and a Logrank test. #, genes that, when inactivated by RNAi, did not significantly affect survival on P. aeruginosa but were colonized by P.
aeruginosa to a significantly higher degree (see Figure S4A).
doi:10.1371/journal.pgen.1000273.t004
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3(wa22) had decreased levels of phosphorylated PMK-1 protein
(Figure 4F), indicating a reduction in basal activity of the p38 MAP
kinase pathway. This decrease in the basal levels of activated
PMK-1 in fat-3(wa22) animals, as opposed to the complete loss of
phosphorylated PMK-1 protein in sek-1(km4) animals, is consistent
with the trends indicated by the qRT-PCR analysis, showing that
the expression levels of infection-response genes in the fat-3(wa22)
mutant were not as low as in the sek-1(km4) mutant (Figure 4A).
The decrease in PMK-1 phosphorylation and immune gene
expression indicate that although the fat-3(wa22) null mutation
does not completely abolish PMK-1 activity, it is sufficient to
compromise immune function in the worm.
As shown in Figure 4B and Table S1, a majority of the
infection-response genes were expressed at wild-type levels in
infected fat-3(wa22) animals. Consistent with this gene expression
data, immunoblot analysis of PMK-1 activation in fat-3(wa22) and
wild-type lysates following a 12-hour exposure to P. aeruginosa
revealed that PMK-1 phosphorylation in the infected fat-3(wa22)
mutant was restored to 81% of that seen in infected wild-type
animals (Figure 4F). By contrast, in sek-1(km4) animals, the level of
phosphorylated PMK-1 protein remained at background following
infection, (Figure 4F), and immunity genes that were expressed at
low levels under basal condition remained low following PA14
infection (Figure 4B). Thus, both the gene expression and PMK-1
phosphorylation analyses support the conclusion that FAT-3 D6-
desaturase is necessary to maintain basal activation of PMK-1 but
appears to be dispensable for PMK-1 activation and the associated
immune gene expression during infection.
Since the loss of fat-3 gene function resulted in the reduced
phosphorylation of PMK-1, fat-3(wa22) mutants are expected to
manifest phenotypes that are associated with a loss or reduction in
p38 MAP kinase signaling. A well-characterized defect of the sek-
1(km4) mutant that is associated with a complete loss of PMK-1
phosporylation is an increased susceptibility to arsenic-induced
oxidative stress [53]. We therefore compared the ability of 1-day-
old adult sek-1(km4) and fat-3(wa22) mutants to survive on 3 mM
arsenic. As expected, fat-3(wa22) and sek-1(km4) animals had
similar survival rate following exposure to arsenic (Figure 4G),
further indicating that the p38 MAP kinase pathway is functionally
compromised in fat-3(wa22) animals.
The increased sensitivity of fat-3 loss-of-function mutants to
pathogen infection and arsenic stress is associated with reduced
basal p38 MAP kinase signaling. Among the genes that positively
regulated by fat-3 are three antimicrobial peptide homologs: spp-1,
which encodes a saposin-like protein, and lys-2 and lys-7 that are
predicted to encode for lysozymes (Figure 4A). This raises the
possibility that the influence of fat-3 on immune function may be
distinct and separable from its arsenic-induced oxidative stress
response. To identify fat-3-regulated genes that are specifically
require for immunity, we inactivated each of the 12 genes down-
regulated in the fat-3(wa22) mutant individually by RNAi and
determined the effects of gene knockdown on pathogen and
arsenic sensitivity. As shown in Table 4, four groups of genes were
identified. Members of the first group, dct-17 and F49F1.1, were
like sek-1(km4) and fat-3(wa22) in that they were required to protect
C. elegans from both pathogen and arsenic. By contrast, inactivation
of the group 2 genes ZK6.11, dod-19 and T01D3.6, had no
detectable effect on pathogen or arsenic survival. Of particular
interest are members of group 3, spp-1, lys-2 and lys-7, F08G5.6
and lec-11, that are specific to immune functions; they were
required to protect C. elegans from P. aeruginosa infection but not
from arsenic-induced oxidative stress. F35E12.8 and gst-38 are
members of group 4 that were not required for C. elegans survival
against infection, but were required for the response to oxidative
stress. Interestingly, gst-38 is predicted to encode a glutathione-S-
transferase that plays an important role in protection from
oxidative stress. We are thus able to distinguish among the fat-3-
regulated genes, a set of immune-specific genes that are distinct
from those required for protection from arsenic toxicity. These
results strongly indicate that fat-3 influences the expression of
genes that have specific role in innate immunity.
Supplementation with GLA and SDA Rescues Basal PMK-
1 Phosphorylation
The specific rescue of fat-3(wa22) survival on P. aeruginosa by GLA
and SDA led us to hypothesize that basal PMK-1 phosphorylation
and expression of infection-response genes would be restored with
the supplementation of these PUFAs. As with the pathogen survival
assay, we determined the effect of PUFA supplementations on the
basal expression of 10 infection-response genes, 6 that were down-
regulated and 4 that were significantly up-regulated in the fat-
3(wa22) mutant, by qRT-PCR (Figure 5). As expected, individual
addition of GLA or SDA fatty acids resulted in a partial restoration
of immune gene expression in uninfected fat-3(wa22) worms, while
simultaneous addition of both fatty acids completely restored the
majority of basal immune gene expression in the fat-3(wa22) mutant
to wild-type levels (Figure 5A), including spp-1, lys-2, lys-7 and lec-11
that are specifically required for immune function (Table 4). By
contrast, supplementation with ALA, AA or EPA, the PUFAs that
did not rescue fat-3(wa22) pathogen sensitivity (Figure 2D), also had
no significant effect on the expression of these misregulated
infection-response genes, with the exception of lec-11 (Figure 5B).
Two genes that had no effect on survival when knocked down by
RNAi; clp-1 and ZK39.6 (data not shown), also did not appear to be
affected by the addition of any of the above PUFAs.
The conclusion that both GLA and SDA are specifically
required for survival against PA14 infection, through the regulated
expression of infection response genes, was further supported by
immunoblot assays that determined the effect of fatty acid
supplementation on PMK-1 phosphorylation (Figure 5C). Sup-
plementation with both GLA and SDA completely restored the
level of phosphoryated PMK-1 in the fat-3(wa22) mutant to wild-
type, indicating that both fatty acids are required to maintain basal
PMK-1 activation, and thus the basal PMK-1-dependent MAP
kinase immune function. Supplementation with ALA, AA or EPA,
on the other hand, had no detectable effect on the levels of
phosphorylated PMK-1 in the fat-3(wa22) mutant.
Supplementation with GLA and SDA also rescued the fat-
3(wa22) response to oxidative stress, again functionally confirming
therestorationofp38MAPkinaseactivitywith the supplementation
of the two missing fatty acids (Figure S6). Supplementation with AA
and EPA had no effect on the oxidative stress response, as expected
from their lack on effect on PMK-1 phosphorylation or gene
expression in the fat-3(wa22) mutant (Figure S6). We thus provide
strong genetic evidence that two specific 18-carbon PUFAs, GLA
and SDA play a vital role in maintaining basal activity of the p38
MAP kinase pathway and consequently influence both immune and
stress responses in C. elegans. That the fat-3 gene, through the
synthesis of SDA and GLA, influences the basal expression of
immune-specific genes, such as spp-1, lys-2 and lys-7,a n dlec-11,
further indicates that fat-3 has a specific role in innate immunity,
independent of its influences on oxidative stresses.
Discussion
Using C. elegans mutants defective in PUFA biosynthesis, and
detailed analysis of the D6-desaturase mutant fat-3(wa22),w e
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omega-3 fat, that play critical roles in basal immunity. Depletion of
GLA and SDA resulted in disrupted basal activity of the p38 MAP
kinase pathway and defective basal immune gene expression, leading
to increased susceptibility to infection by P. aeruginosa.W ea l s o
demonstrated that fat-3 is required in the intestine, the site of P.
aeruginosa infection, to protect C. elegans from pathogen-mediated
death and to regulate the expression of immunity genes. The p38
MAP kinase pathway is required to protect C. elegans from infection
and oxidative stress. Importantly, we showed that fat-3,t h r o u g ht h e
synthesis of GLA and SDA, affects the expression of a subset of genes
that are specifically required for immune function but not oxidative
stress response. We further showed that loss of fat-3 gene function
does not result in a general loss of defense against stresses, and
provided evidence that support an independent role for GLA and
SDA in innate immunity.
Fatty acid desaturases have previously been shown to have
important roles in innate immunity in mammals and plants. In
Figure 5. Supplementation with GLA and SDA rescues immune gene expression and PMK-1 phosphorylation. A, B. qRT-PCR analysis of
basal immune gene expression in PUFA supplemented fat-3(wa22) animals. Exogenous supplementation with GLA and SDA rescues immune gene
expression (A), while supplementation with 20-carbon PUFAs does not (B). Data are depicted as mean6s.e.m and represent fold difference in
expression relative to wild-type animals on OP50-1. Significance was determined using the student’s t-test. *, gene expression not significantly
different (p.0.05) from wild-type, which is set at 1; Student’s t-test. Horizontal lines in panels A and B identify genes that are specifically required for
survival against PA14 infection (see Table 4). C. Immunoblot analysis of PMK-1 phosphorylation in fat-3(wa22) animals supplemented with 18- and 20-
carbon PUFAs. Arrow on right indicates additional non-specific band seen with the phospho-p38 specific antibody. Abbreviations: AA, arachidonic
acid; ALA, alpha-linolenic acid; EPA, eicosapentaenoic acid; GLA, gamma-linolenic acid; SDA, stearidonic acid.
doi:10.1371/journal.pgen.1000273.g005
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required for the production of immune effector molecules.
SCD1 catalyses the D9 desaturation of 16- and 18-carbon
saturated fatty acids into the monounsaturated palmitoleic (PLA,
16:1n9) and OA that are bactericidal against Gram-positive
pathogens. Consequently, mice carrying loss of function SCD1
mutations are defective in clearing skin infections by Streptococcus
pyogenes and Staphylococcus aureus [54]. Whether these MUFAs are
also involved in immune signaling remains to be investigated. In
plants, mutants in the Arabidopsis SSI2/FAB2 gene, which encodes
a D9 desaturase, show enhanced resistance to bacterial and
biotrophic oomycete fungal pathogens but increased susceptibility
to a necrotrophic fungal pathogen [55–57]. The immune
phenotypes of the ssi2 mutant are due to low levels of OA, which
leads to the constitutive activation of the salicylic acid-dependent
immune pathway and repression of the jasmonic acid (JA)-
dependent pathway by unknown mechanism(s) [55,57,58].
Disruption of another desaturase that catalyzes the conversion of
LA to ALA, encoded by the spr2 gene in tomato plants and fad-7
and fad-8 in Arabidopsis, also results in diminished JA signaling and
a reduced response to wounding by insects and infection by fungal
pathogens [59–61]. Similar to the lipid-dependent manipulation of
immune signaling in plants, we showed for the first time that GLA
and SDA, the products of FAT-3, an animal D6 desaturase, are
required to maintain basal expression of immunity genes through
their effect on the phosphorylation of a C. elegans p38 MAP kinase
homolog, PMK-1.
In mammals, the omega-6 and omega-3 18-carbon PUFA
families cannot be synthesized de novo. They must be produced
from the dietary essential fatty acids, LA and ALA through a series
of elongation and desaturation reactions. LA and ALA have
relatively little pharmacologic action of their own; their effects
derive largely from metabolic processing to more active end
products. The human ortholog of the C. elegans FAT-3 enzyme,
fatty acid desaturase 2 (FADS2) regulates production of GLA and
SDA from their LA and ALA precursors [62]. This reaction is slow
and can be further impaired by numerous factors, including aging,
nutrient deficiencies, diabetes, hypertension, and life style factors,
such as stress, smoking and excessive alcohol consumption [63,64].
Thus, reduced dietary intake of LA and ALA, coupled with any of
these conditions could lead to insufficient production of GLA and
SDA in the body, potentially leading to compromised basal
immunity analogous to the C. elegans fat-3(wa22) mutant. Reduced
activity of FADS2 could also result in the decreased production of
down-stream metabolites, such as the inflammatory mediators AA
and EPA [64].
As noted above, we have provided several lines of evidence that
the decreased ability of fat-3 mutants to survive infection by P.
aeruginosa is a consequence of diminished synthesis of GLA and
SDA (Figure 2). By contrast, the 20-carbon PUFAs, AA and EPA
appear to have minimal effects on the infection response to P.
aeruginosa. Mutants deficient in different 20-carbon PUFAs, such as
elo-1(gk48), elo-1(wa7), fat-1(wa9), fat-4(ok958) and fat-4(wa14) show
no defects in their response to infection (Figure 2A). Although
supplementation with AA or EPA was sufficient to restore many of
the additional defects displayed by the fat-3(wa22) mutant, neither
of these PUFAs had any significant effects on the immune defects
of fat-3(wa22), as measured by survival on pathogen, expression of
immune-specific genes and phosphorylation of PMK-1. In
mammals, AA can be metabolized by cyclooxygenase, lipoxygen-
ase and cytochrome P-450 (CYP) enzymes to produce important
signaling molecules [3]. Since the C. elegans genome does not
contain obvious orthologs of mammalian cyclooxygenases and
lipoxygenases or of prostanoid and leukotriene receptors, a role for
prostaglandin and leukotrienes in lipid signaling can be largely
excluded. However, C. elegans shares with mammals the capacity to
produce CYP-dependent eicosanoids. Recently, it was demon-
strated that C. elegans contains microsomal monooxygenase
systems, consisting of CYP-29A3 and CYP-33E2 cytochromes
and an EMB-8 microsomal NADH-cytochrome c reductase that
catalyze the epoxidation and hydroxylation of EPA and AA to
specific sets of epoxy- and hydroxy-derivatives [65]. The ability of
C. elegans to generate endogenous CYP-dependent eicosanoids
could be blocked by inhibitors, such as adamantyl-3-dodecyl urea
(ADU) developed against mammalian soluble epoxide hydrolases
[65] suggesting that this component of eicosanoid metabolism may
be conserved between C. elegans and mammals [66]. CYP-derived
eicosanoids have been implicated in a variety of critical biological
processes in humans, including homeostasis and inflammation
[67]. Although our genetic analysis indicates that AA and EPA
have no significant effect on the ability of C. elegans to survive
infection by bacterial pathogens, we cannot not rule out other, as
yet unidentified, roles for these 20-carbon fatty acids in the
immune response.
CYP enzymes also play a role in the synthesis of oxylipins,
oxygenated fatty acids synthesized from precursor PUFAs [68].
Oxylipins are typically derived from cis PUFAs, such as LA, ALA
or AA [15], and act as signaling and effector molecules. Among
the best known oxylipins are jasmonic acid and its derivatives that
form vital signaling and effector molecules in plant immune
responses [16]. In mammals, eicosanoids form one of the major
groups of oxylipins, and are potent modulators of various
physiological processes, including the regulation of inflammation
[4–6]. Many oxylipins also show direct antimicrobial activities
against bacteria, fungi and oomycetes [69–71]. A recent report
indicated that in Cyanobacteria, GLA and SDA can be converted to
oxylipins by CYP enzymes, but this process is not well
characterized [72]. Little is known of oxylipin synthesis in C.
elegans, but the presence of functional cytochrome P-450 enzymes
leaves open the possibility that GLA and SDA could be processed
into functional signaling molecules or immune effectors that
directly influence the immune response. Future work will focus on
determining if deficiency in CYP-derived eicosanoids or oxylipins
could affect innate immune function in C. elegans.
The disruption of the FAT-3 D6-desaturase also resulted in
altered immune gene expression and defective basal p38 MAP
kinase activity (Figure 4). We demonstrate that this reduction in
basal activity of p38 MAP kinase signaling and the concomitant
increased susceptibility to both infection and oxidative stress, due
to loss of fat-3 function, are associated with GLA and SDA
deficiencies. In C. elegans, the p38 MAP kinase is required for both
the basal and induced expression of genes in response to infection
[28] and functions through the activation of the p38 MAP kinase
ortholog, PMK-1. Under normal growth conditions, this pathway
is active as low levels of phosphorylated PMK-1 can be detected.
We present the first evidence that the maintenance of PMK-1
basal activity requires GLA and SDA. Depletion of GLA and SDA
in the fat-3(wa22) mutant significantly reduced the levels of
phosphorylated PMK-1, without affecting the PMK-1 protein
levels. This disruption further resulted in the altered basal
expression of a number of immunity genes, as well as an increased
susceptibility to oxidative stress. Despite retaining an intact
response to infection in the absence of GLA and SDA, reduction
in basal p38 MAP kinase signaling in the fat-3 mutant was
sufficient to cause increased susceptibility to both infection and
oxidative stress, highlighting the vital importance of basal
immunity. Previous research has similarly demonstrated the
importance of this constitutive response in mammals and other
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part of the constitutive immune response, and are continuously
expressed in many epithelial tissues. Mice deficient in the
production of the lung b-defensin-1 (mBD-1) showed defects in
their ability to clear H. influenzae infections from the lung [73]. In
this case, however, the mBD-1 mutant mice were defective in both
the constitutive as well the inducible expression of the single
effector molecules. Here, with the fat-3 mutant, we demonstrate
the essential requirement of a constitutive immune response
pathway for survival against the pathogen, despite the presence of
a functional inducible infection response in C. elegans. It would be
additionally interesting to determine if GLA and SDA deficiencies
in humans are also associated with reduced p38 MAP kinase
activity and hypersensitivity to infection, and if these pathophys-
iological conditions could be restored through dietary supplemen-
tation of GLA and SDA.
The mechanism by which GLA and SDA affect the activity of
p38 MAP kinase signaling and immune gene expression is
currently unknown. GLA and SDA have a range of actions, and
future work will be required to determine if their effects are direct
or indirect. Lipids form a major constituent of cell membranes,
and the effects of GLA and SDA may be associated with their
influence on the physical properties of these membranes. The
extent of membrane fatty acid unsaturation is known to influence
membrane structure, fluidity and permeability [74]. Membrane
fluidity is the extent of molecular disorder and molecular motion
within the lipid bilayer [75]. This physical state of the membrane
lipid can act directly to regulate membrane-bound proteins, such
as receptor-associated protein kinases and ion channels, leading to
alteration of gene expression [76,77]. Thus, the effect of GLA and
SDA depletion on reduced signaling through the p38 MAP kinase
pathway may be linked to their effects on membrane fluidity,
perhaps analogous to osmoregulation in yeast. When glucose was
added to yeast medium to raise osmolarity, an associated reduction
in membrane fluidity was observed [78]. When shifted to high
osmolarity, yeast cells rapidly stimulate a MAP kinase cascade, the
high-osmolarity glycerol (HOG) pathway, which orchestrates part
of the transcriptional response [79]. Alternatively, the levels of
SDA and GLA could affect lipid-protein interactions of membrane
receptors and thus the intensity of signaling, analogous to the
effects of OA on G protein coupled receptor (GPCR)-associated
signaling. Addition of OA alters membrane structure and results in
reduced G protein receptor activity in 3T3 cell derived
membranes [80]. GPCRs are capable of activating MAPKs using
an intricate signaling network [81]. It would be interesting to
determine if depletion of GLA and SDA results in changes in
membrane structure or fluidity that leads to reduced p38 MAP
kinase signaling, through their effects on GPCRs or other
membrane-associated signaling molecules.
Another important aspect of a cell membrane is its selective
permeability, which plays a vital role in maintaining cell integrity
and preventing entry of toxins [82]. Given that most pathogens
secrete toxins and hydrolytic enzymes that can harm host cells,
membrane permeability might affect the outcome of an infection.
The fat-3(wa22) mutant is more sensitive to the detergent Triton
X-100, potentially pointing to a defect in cell membrane
permeability. However, the detergent sensitivity of the fat-
3(wa22) mutant could be rescued without affecting its sensitivity
to P. aeruginosa infection (Table 3, Figure 2C,D), indicating that the
potentially altered cell membrane permeability of the fat-3(wa22)
mutant does not impact immune function. Of note is that the fat-
3(wa22) mutant also has a defective cuticle [42], which could
account for, or partly influence, the detergent sensitivity of the fat-
3(wa22) mutant, rather than a defect in membrane permeability.
Lipids perform a multitude of roles in the immune system,
influencing both the innate and adaptive immune responses to
infection. While their roles as inflammatory precursors is well
known, studies have also identified lipid derived ligands that
function through the mammalian Peroxisome Proliferators
Activated Receptors (PPARs) to modulate the adaptive T cell
response [83] and activate NK cells and dendritic cells [9,10].
PPARs are a subset of nuclear hormone receptors (NHRs), a
family of transcription factors activated by small lipophilic ligands
that control a number of metabolic and systemic processes. In
mammals, GLA is primarily converted to DGLA, a precursor of
anti-inflammatory eicosanoids [64]. In keratinocytes, however,
GLA treatment also results in the induction of COX-2 expression
in a PPAR-c-dependent manner. Addition of GLA results in the
translocation of PPAR-c to the nucleus and a consequent increase
in COX-2 promoter activity and COX-2 protein levels in the cell
[84]. This suggests a possible direct signaling role for GLA in
regulating expression of the COX-2 gene, through PPAR-c to
mediate inflammatory immune responses. C. elegans has no known
inflammatory response but does posses 284 putative NHRs [85],
several of which affect the fat content [33] or the lipid metabolism
of the worm [34,86]. A number of these NHRs are differentially
regulated in response to infection [27,28], and reducing expression
of nhr-112, by RNAi, results in increased sensitivity to infection by
P. aeruginosa [27]. The interaction between lipid ligands, NHRs
and the MAP kinase pathways has been explored previously in the
context of the PPAR receptors in mammalian systems. In CD4
+ T
cells, unliganded PPARa suppresses p38 MAP kinase phosphor-
ylation. Activation of PPARa by its lipid ligand relieves this
restraint, allowing phosphorylation and activation of the MAP
kinase pathway to induce cytokine production in these T cells [87].
Conversely, the p38 MAP kinase pathway has also been
implicated in the control of PPARa activation and function. In
vitro analysis shows that phosphorylation by p38 MAP kinase
enhances activity of PPARa in cardiomyocytes [88], suggesting the
possibility for similar complex interactions between the GLA and
SDA PUFAs, NHRs and the p38 MAP kinase pathway in C. elegans
innate immune function.
In summary, the demonstration that GLA and SDA are
required for basal immunity adds to out understanding of the
varied roles for lipids in immunity. Disrupting the synthesis of
GLA and SDA leads to an increased sensitivity to infection, and
the disrupted basal activity of the p38 MAP kinase pathway. Given
that numerous conditions, including aging, diabetes, stress and
smoking could lead to GLA and SDA deficiencies, it will be of
interest to explore the roles for these PUFAs in other organisms,
including humans.
Materials and Methods
Worm and Bacterial Strains
The strains fat-2(wa17), fat-3(wa22), elo-1(wa7), elo-1(gk48), fat-
1(wa9), fat-4(ok958), fat-4(wa14), daf-16(mu86), sma-6(wk7), sek-
1(km4), pmk-1(km25) and pha-1(e2123) were obtained from the
Caenorhabditis Genome Center (CGC). The fat-6(tm331) strain was
obtained from Dr. Shohei Mitani (National BioResource Project,
Japan). The fat-7(wa36) and the fat-6(tm331); fat-7(wa36) double
mutant were gifts from Dr. Jennifer Watts (Washington State
University). fat-3(lg8101) and the tissue specific rescue strains were
gifts from Dr. Giovanni M Lesa (University College London). All
strains were grown on nematode growth media (NGM) plates at
25uC and fed with the E. coli strain OP50-1 unless noted otherwise.
For the assays described below, unless noted otherwise, all the
worms were grown at 25uCo nE. coli HT115 expressing the pos-1
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Bacteria expressing dsRNA directed against pos-1, sek-1, lys-7 and
lec-11 were part of a C. elegans RNAi library expressed in E. coli
strain HT115 (Geneservice, Cambridge, U.K.). Bacteria express-
ing dsRNA directed against spp-1, lys-2, dct-17, ZK6.11, dod-19,
F49F1.1, F35E12.8, F08G5.6, gst-38, T01D3.6 were part of a C.
elegans library expressed in E. coli strain HT115 (Open Biosystems,
Huntsville, Alabama). All bacterial strains were cultured under
standard conditions at 37uC.
Fatty Acid Supplementation
ALA, AA and EPA supplements were obtained from NuChek
Prep Inc., GLA was obtained from Sigma-Aldrich Co., while SDA
was obtained from Cayman chemicals Co. Fatty acids were
dissolved in 95% ethanol, and were added to a final concentration
of 4 mM to E. coli HT115 carrying the pos-1 RNAi construct and
allowed to dry overnight in the dark. Wild-type animals fed pos-1
RNAi bacteria supplemented with an equivalent amount of
ethanol were used as controls. Worms were allowed to grow on the
supplements from egg to one-day-old adults at a temperature of
25uC. For adult supplementation assays, young adult animals were
placed on supplement plates for 48 hours before transfer.
Supplementation, in each case, was verified by GC-MS, and
collected worms were used for multiple assays.
Survival Assays
Survival assays were performed as described [27]. Plates were
scored every 12 hours, and worms that showed no response to
touch were scored as dead. Worms that died due to desiccation or
by bagging due to live progeny were excluded from the analysis.
Statistical analyses were performed using a Kaplan-Meier non-
parametric comparison and a Logrank test, using Statview
(Version 5.0.1, SAS Institute Inc.). All assays were repeated a
minimum of three times, with approximately 120 worms tested per
condition in each assay.
Gas Chromatography and Mass Spectometry (GC-MS)
Synchronized populations of several thousand adult worms
were harvested at appropriate time points and washed with M9
buffer to remove excess bacteria. Worm pellets were treated with
3% H2SO4 in methanol and incubated at 80uC for 2 hours. Fatty
acids were extracted as described previously [32] and analyzed by
GC-MS using an HP 6890 gas chromatograph equipped with an
HP-5MS column (30 m60.25 mm625 mm).
Quantitative Real Time-PCR (qRT-PCR)
One-day-old adult animals were exposed to OP50-1, PA14 or
PA14DgacA for 12 hours. For supplementation assays, worms were
allowed to develop from embryos to young adults in the presence
of fatty acids prior to analysis. RNA extraction and qRT-PCR
were performed as previously described [27]. 25 ml reactions were
performed using the iScript One-Step RT-PCR kit with SYBR
green according to the manufacturer’s instructions (BioRad
Laboratories, Hercules, CA). Cycling threshold (Ct) values were
normalized to mRNA levels of three primer pairs, pan actin (act-
1,3,4), F44B9.5 and ama-1, which did not change with infection.
Values and statistical analyses were calculated from normalized
cycle threshold values prior to conversion to relative fold change.
Colonization
Colonization assays were performed on slow killing plates using
a GFP-expressing PA14 strain (PA14-GFP) [38] and the pha-
1(e2123) temperature sensitive mutant strain, to avoid the presence
of progeny on the assay plates at the restrictive temperature of
25uC. Adult worms were exposed to PA14-GFP for 24 hours and
the intestinal bacterial load was determined under a fluorescence
microscope. The degree of colonization was determined as follows:
worms with a lumen completely packed with PA14-GFP were
classified as fully colonized, worms that showed a limited presence
of GFP in the intestine were classified as partially colonized and
worms with no detectable GFP expression in the intestine were
classified as having undetectable levels of colonization. A
minimum of 2 independent experiments was performed with a
total of 60 worms per sample per time point for each experiment.
Statistical analyses were performed using Chi-square tests.
Life Span
Life span assays were performed on NGM plates containing
0.1 mg/ml FUDR to prevent progeny from hatching [90]. Plates
were seeded with concentrated OP50-1 and allowed to dryovernight.
A synchronized population of L4 worms was placed onto the plates
and scored every 24 hours. All strains were compared to the wild-
type Bristol N2 strain and approximately 120 worms were used per
strain per experiment. Statistical analyses were performed using a
Kaplan-Meier non-parametric comparison and a Logrank test, using
Statview (Version 5.0.1, SAS Institute Inc.).
Immunoblot Analysis
Adult worm samples were washed with M9 and frozen for
analysis. Animals were homogenized in M9 buffer and protein
content was measured with a BCA Protein Assay Kit (Thermo
Fisher Scientific Inc.) before loading. A phospho p38 specific
monoclonal antibody (Cell Signaling Technology, Inc.), a p38
specific antibody (Cell Signaling Technology, Inc.) and an anti-
actin antibody (Sigma-Aldrich Co.) were used at concentrations of
1:1000, 1:250 and 1:250 respectively.
Arsenic and Aldicarb Assays
Slow killing plates were coated with a final concentration of
3 mM sodium arsenite and allowed to dry overnight [53]. Plates
were then seeded with E. coli OP50-1 and approximately 30 adult
worms were placed on each plate, for a total of 120 worms per
strain. Plates were scored every 12 hours and worms that showed
no response to touch were counted as dead. Aldicarb (2-methyl-2-
[methylthio]- propionaldehyde O-[methylcarbamoyl]oxime;
Chem Services, West Chester, PA) stocks were dissolved in
acetone and added to a final concentration 0.7 mM onto NGM
plates [91]. Plates were allowed to dry overnight in the dark and
then seeded with E. coli OP50-1. 30 adult worms were placed on
each plate and monitored every 4–6 hours for paralysis, with
approximately 120 worms used per strain/treatment for each
experiment. Statistical analyses were performed using Kaplan-
Meier non-parametric comparisons and Logrank tests, using
Statview (Version 5.0.1, SAS Institute Inc.).
Defecation and Movement Assays
Defecation assays were performed as described [42]. Defecation
cycles were measured as the time between successive posterior
body contractions over a period of five minutes. All assays were
conducted in closed Petri dishes seeded with OP50-1, and a
minimum of six adult animals was scored for per strain for each
fatty acid treatment. Movement assays were performed as
described [92] with M9 buffer in 96-well microtiter plates. A
minimum of six animals was scored for total number of thrashes
within a period of 2 minutes. One ‘thrash’ was defined as a change
in the direction of bending at the mid-body.
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Metal toxicity assays were performed as described [44]. Briefly,
sets of three 1-day-old adults were allowed to lay eggs on plates
containing either CdCl2 (30 mM) or CuSO4 (250 mM), for
3 hours. Adult worms were then removed, and the number of
eggs on each plate was determined. After incubation at 25uC for
48 hours, the number of surviving adults was counted. The
percentage of adults was determined as total number of adults
divided by total number of eggs. For PUFA supplementation
assays, fatty acids were added to the bacteria before seeding the
plates. One-day-old adult animals were incubated in a solution of
1% Triton X-100 for one hour. Following removal from the
detergent solution and one-hour recovery on NGM plates at 25uC,
the number of survivors was determined. For supplementation
assays, worms were grown in the presence of different fatty acids,
before being placed in the detergent solution.
Thermal Stress Assay
Heat and cold stress assays were carried out as described [93].
One-day-old adult animals were exposed to 0uCo r3 6 uC for a
period of 24 hours and 10 hours, respectively. Number of
survivors was determined following one-hour recovery at 25uC.
Significant differences in thermal tolerance were determined using
a Student’s t-test.
Supporting Information
Figure S1 Fatty acid composition and virulence of OP50-1,
PA14 and PA14DgacA.A .P. aeruginosa PA14 and PA14DgacA are
similar in fatty acid content, but are highly divergent from E. coli
OP50-1. GC-MS analysis was used to measure and identify species
of fatty acids. Relative abundance of different fatty acid species are
expressed as fraction of total fatty acids and depicted as
mean6s.e.m. *, p#0.001 between OP50-1 and PA14; Student’s
t-test. Abbreviations: PA, palmitic acid; PLA, palmitoleic acid; VA,
vaccenic acid; MHA, cis-9,10 methylene hexadecanoic acid;
MOA, cis-11,12 methylene octadecanoic acid. B. PA14DgacA is
highly attenuated compared to the wild-type PA14. Survival
analysis of wild-type worms exposed to OP50-1, PA14 and
PA14DgacA. Graph depicts fraction of worms alive plotted as a
function of time. *, p#0.001 compared to OP50-1; Kaplan Meier
non-parametric comparison and a Logrank test.
Found at: doi:10.1371/journal.pgen.1000273.s001 (0.5 MB TIF)
Figure S2 Exogenous PUFA supplementation restores levels of
depleted fatty acids. (A) Wild-type worms simultaneously supple-
mented with GLA and SDA, or individually with AA or EPA. N,
p#0.001 between supplemented and untreated wild-type animals;
Student’s t-test. fat-3(wa22) supplemented with GLA and SDA (B),
AA (C) or EPA (D). Relative lipid levels are expressed as percent of
total LCFAs measured and represent mean6s.e.m. from three
independent experiments. *, p#0.001 compared to wild-type for
fat-3(wa22); #,p #0.001 compared to wild-type for fat-3
supplemented with GLA+SDA; D,p #0.001 compared to wild-
type for fat-3 supplemented with AA; ,,p #0.001 compared to
wild type for fat-3 supplemented with EPA; Student’s t-test.
Abbreviations: AA, arachidonic acid; ALA, alpha-linolenic acid;
DGLA, dihomo-c-linolenic acid; EPA, eicosapentaenoic acid;
GLA, gamma-linolenic acid; LA, linoleic acid; O3AA, v-3
arachidonic acid; OA, oleic acid; PA, palmitic acid; PLA,
palmitoleic acid; SA, stearic acid; VA, vaccenic acid.
Found at: doi:10.1371/journal.pgen.1000273.s002 (4.4 MB TIF)
Figure S3 Exogenous PUFA supplementation has no effect on
survival of wild-type and elo-1(gk48) animals. A, B. Exogenous
PUFA supplementation has no effect on survival of wild-type
animals against PA14 infection. Survival analysis of wild-type
animals supplemented with 18-carbon (A) or 20-carbon (B)
PUFAs. C. GLA supplementation in adult fat-3(wa22) animals
partially rescued survival. Adult fat-3(wa22) animals were supple-
mented with ALA, GLA or SDA for a period of 48 hours before
exposure to PA14. D. 18-carbon PUFA supplementation has no
effect on PA14 resistant elo-1(gk48) animals. All graphs depict
fraction of worms alive as a function of time. *, p#0.001
compared to wild-type; Kaplan Meier non-parametric comparison
and a Logrank test. Abbreviations: AA, arachidonic acid; ALA,
alpha-linolenic acid; EPA, eicosapentaenoic acid; GLA, gamma-
linolenic acid; SDA, stearidonic acid.
Found at: doi:10.1371/journal.pgen.1000273.s003 (3.7 MB TIF)
Figure S4 Misregulated expression of infection-response genes in
infected fat-3(wa22) animals. A. Increased rate of bacterial coloniza-
tion in lec-11 and F49F1.1 RNAi-treated animals challenged with
PA14-GFP compared to wild-type (p#0.001; Chi-square test).
Animals grown on RNAi bacteria were exposed to PA14-GFP and
monitored for extent of intestinal colonization after 24 h. Figure
depicts percent of worms in each colonization category, for each
RNAi gene target. B. Expression levels of infection response genes
significantly altered in PA14 infected fat-3(wa22) animals (p#0.05;
Student’s t-test). Data are depicted as mean6s.e.m., and represent
fold expression relative to wild-type animals infected with PA14.
Found at: doi:10.1371/journal.pgen.1000273.s004 (1.6 MB TIF)
Figure S5 Intestinal fat-3 expression restores basal expression of
infection response genes. A. qRT-PCR analysis of infection-
response gene expression in fat-3(lg8101) transgenic animals
expressing the fat-3 gene under its endogenous promoter. B-D.
Effect of intestinal (B), neuronal (C) or muscle (D) specific fat-3
expression on basal infection-response gene expression. Graphs
depict mean6s.e.m. and represent fold difference in gene
expression relative to wild-type animals on OP50-1, with wild-
type set to 1. #,p .0.05 for the fat-3; [Pfat-3::fat-3] strain. n, N, ,,
p.0.05, respectively for the intestine- (Pelt-2::fat-3), muscle- (Pmyo-
3::fat-3) and neurons- (Punc-119::fat-3) specific fat-3 rescue strains
compared to wild-type; Student’s t-test. Horizontal line under each
graph identifies genes that are specifically required for survival
against PA14 infection (see Table 4).
Found at: doi:10.1371/journal.pgen.1000273.s005 (3.6 MB TIF)
Figure S6 Exogenous PUFA supplementation restores fat-3
response to oxidative stress. Supplementation with GLA and
SDA rescues fat-3 susceptibility to oxidative stress. Untreated and
PUFA supplemented animals were placed on plates containing
3 mM arsenic, and survival was determined every 12 h. Graph
depicts fraction of worms alive plotted as a function of time. *,
p#0.001 compared to wild-type; Kaplan Meier non-parametric
comparison and a Logrank test. Abbreviations: AA, arachidonic
acid; EPA, eicosapentaenoic acid; GLA, gamma-linolenic acid;
SDA, stearidonic acid.
Found at: doi:10.1371/journal.pgen.1000273.s006 (2.2 MB TIF)
Table S1 Analysis of 50 stress- and infection-response genes. q-
RT PCR analysis of stress- and infection-response gene expression
in uninfected and P. aeruginosa-infected wild-type, fat-3(wa22), sek-
1(km4),pmk-1(km25),daf-16(mu86)andsma-6(wk7)animals.Dataare
depictedasCtvaluesrelative towild-type6s.e.m. (Ctwild-type – mutant)
and represent average values of three independent experiments.
Student’s t-test was used to determine significant differences in gene
expression.
Found at: doi:10.1371/journal.pgen.1000273.s007 (0.04 MB
XLS)
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different fat-3 alleles. Comparative qRT-PCR analysis of expres-
sion of 12 infection and stress-response genes between wild-type,
fat-3(wa22) and fat-3(lg8101). Data are depicted as Ct values
relative to wild-type6s.e.m. (Ctwild-type–mutant) and represent
average values of three independent experiments. * p.0.05
compared wild-type; Student’s t-test.
Found at: doi:10.1371/journal.pgen.1000273.s008 (0.05 MB
DOC)
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